Ace the Case: A 62-Year-Old Woman With a Pelvic Mass, Ascites, and an Elevated Ca-125 Level
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Angle PLC- Ovarian Cancer Study Patient Enrolment Completed
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.
ANGLE plc: Angle PLC- Ovarian Cancer Study Patient Enrolment Completed
Headline results from the Study expected in Q4 2021
Study designed to support launch of an ovarian cancer test from ANGLE s clinical laboratories in the United States and the UK
GUILDFORD, SURREY, UK / ACCESSWIRE / April 26, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce that its 200 patient ovarian cancer clinical verification study ( the Study ) has completed patient enrolment.
The Study, undertaken by the University of Rochester Medical Center Wilmot Cancer Institute, New York, USA (URMC), is designed to evaluate the use of ANGLE s Parsortix
® system for circulating tumour cell (CTC) harvest and subsequent downstream analysis with ANGLE s HyCEAD multiplex RNA platform as a simple blood test to detect the presence of ovarian cancer in women with a pelvic mass prior to surgery.